ADS-5102

amantadine · Adamas Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ADS-5102, covering 2017-08-08 to 2022-01-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment [Phase 3]